Exagen Diagnostics Inc. Partners with Medco Research Institute® to Develop ... - PR Newswire (press release)

Exagen Diagnostics Inc. Partners with Medco Research Institute® to Develop ... PR Newswire (press release) Pilot program utilizes Exagen's Avise PG(SM) specialized blood-testing service to help physicians optimize treatment therapies for patients with rheumatoid arthritis. FRANKLIN LAKES, NJ, and ALBUQUERQUE, NM, May 23, 2011 /PRNewswire/ -- Exagen ... Exagen, Medco partner on arthritis testBizjournals.com all 13 news articles »

Abbott Labs Sued on Claims Humira Caused Permanent Eye Damage - Bloomberg

Abbott Labs Sued on Claims Humira Caused Permanent Eye Damage Bloomberg Humira was originally approved in 2003 as a treatment for rheumatoid arthritis. The US Food and Drug Administration has since approved it to treat five additional autoimmune diseases, including Crohn's. Bixby said Abbott should have known Humira could ... and more »

Safety of biologics varies, but not by much - Rheumatology Update

Safety of biologics varies, but not by much Rheumatology Update The risk of serious infections among patients taking biological agents for rheumatoid arthritis is much more dependent on patient factors than on which drug they are taking, concludes a study showing that infliximab is ... and more »

Zalicus Up in 2011; Expected to Rise Higher - Seeking Alpha

Zalicus Up in 2011; Expected to Rise Higher Seeking Alpha The first application is rheumatoid arthritis, where patients eventually advance from oral drugs to expensive injected biologics. Synavive can delay the need to put a patient on a 00 a month injectable, with a once-a-day oral drug (much preferred by ...